JPH0156071B2 - - Google Patents

Info

Publication number
JPH0156071B2
JPH0156071B2 JP55060460A JP6046080A JPH0156071B2 JP H0156071 B2 JPH0156071 B2 JP H0156071B2 JP 55060460 A JP55060460 A JP 55060460A JP 6046080 A JP6046080 A JP 6046080A JP H0156071 B2 JPH0156071 B2 JP H0156071B2
Authority
JP
Japan
Prior art keywords
group
formula
metanitrobenzyloxy
compound
metacyanobenzyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55060460A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55149272A (en
Inventor
Rangurowa Mitsusheru
Rakuuru Aran
Byuushe Berunaaru
Moketsuto Jizeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of JPS55149272A publication Critical patent/JPS55149272A/ja
Publication of JPH0156071B2 publication Critical patent/JPH0156071B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
JP6046080A 1979-05-07 1980-05-07 Novel 5hhfuranonee2 and 3hhdihydrofuranonee2 derivative* their manufacture and use as medicine Granted JPS55149272A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7911453A FR2456097A1 (fr) 1979-05-07 1979-05-07 Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
JPS55149272A JPS55149272A (en) 1980-11-20
JPH0156071B2 true JPH0156071B2 (enExample) 1989-11-28

Family

ID=9225124

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6046080A Granted JPS55149272A (en) 1979-05-07 1980-05-07 Novel 5hhfuranonee2 and 3hhdihydrofuranonee2 derivative* their manufacture and use as medicine

Country Status (4)

Country Link
US (1) US4346102A (enExample)
JP (1) JPS55149272A (enExample)
FR (1) FR2456097A1 (enExample)
ZA (1) ZA802673B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351839A (en) * 1981-03-30 1982-09-28 Rohm And Haas Company Fungicidal 2-aryl-2-1-H-azoyl-(alkyl)-gamma-butyrolactones
JPS5916884A (ja) * 1982-07-19 1984-01-28 Fujisawa Pharmaceut Co Ltd 新規フラン化合物
WO1997010235A1 (en) * 1995-09-15 1997-03-20 Pharmacia & Upjohn Company 5-AMIDOMETHYL α, β-SATURATED AND -UNSATURATED 3-ARYL BUTYROLACTONE ANTIBACTERIAL AGENTS
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2456097B1 (enExample) 1983-01-14
ZA802673B (en) 1981-05-27
JPS55149272A (en) 1980-11-20
FR2456097A1 (fr) 1980-12-05
US4346102A (en) 1982-08-24

Similar Documents

Publication Publication Date Title
CA2107484C (fr) Nouveaux arylalkyl(thio)amides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CH653999A5 (fr) Derives aminomethyl-5 oxazolidiniques, procede de preparation et composition pharmaceutique.
CH620436A5 (enExample)
CH637927A5 (fr) Derives de 4-amino-5-alkylsulfonyl ortho-anisamides et leurs procedes de preparation.
EP0286516B1 (fr) Nouveaux dérivés de l'amino tétrahydro-5,6,7,8 naphto [2,3b] furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP0833822A1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US4207343A (en) 1-Phenyl-3-(substituted phenoxy)propylamines
JPS59108749A (ja) ５−｛（ｒ）−１−ヒドロキシ−２−〔（ｒ）−（１−メチル−３−フエニルプロピル）アミノ〕エチル｝サルチルアミドまたはその薬理学的に許容される酸付加塩の製造方法
FR2674849A1 (fr) Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
EP2300424B1 (fr) Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
CA1228359A (fr) Procede de preparation de nouveaux derives de la quinoleine
FR2883000A1 (fr) Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
CA2000091A1 (fr) Derives de la benzoxazolinone, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH03101643A (ja) ハロゲノアルキルフェニルアルコール、ケトンおよびそれらの水和物
JPH0314548A (ja) ２―アミノ―７―ヒドロキシテトラリンカルボキシアルキルエーテル類およびその製造方法
CA2178302C (fr) Nouveaux derives de l'indole, de l'indazole et du benzisoxazole,leur pr ocede de preparation et les compositions pharmaceutiques qui les contiennent
JPH05506236A (ja) 環状ヒドロキサム酸およびその用途
JPS5980668A (ja) Ｎ−アリル化オキサゾリジン−２−オンの光学活性な誘導体、該誘導体の製法及び該誘導体による薬剤
BE885303A (fr) Glycinamides
WO2000058301A1 (fr) Derives de n-[2-(4-aminophenyl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-methanamine, leur preparation et leur application en therapeutique
JPS61165323A (ja) パ−キンソン疾患治療剤
FR2679907A1 (fr) Nouveaux n-[(isoquinolein-5 yl)sulfonyl] azacycloalcanes, leur procede de preparation et les compositions pharmaceutiques les contenant.
CA1062265A (fr) Procede de preparation de nouvelles benzylamines
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine